Lamotrix Indications/Uses

Epilepsy: Adults and children over 12 years of age: Adjunctive or monotherapy in the treatment of epilepsy, for partial seizures and generalized seizures including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome.
Children 2 to 12 years of age: Lamotrigine is indicated as adjunctive therapy in the treatment of epilepsy, for partial seizures and generalised seizures including tonic-clonic seizures and the seizuies associated with Lennox-Gastaut Syndrome.
Initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.
After epileptic control has been achieved during adjunctive therapy, concomitant anti-epileptic drugs (AEDs) may be withdrawn and patients continued on lamotrigine monotherapy.
Bipolar Disorder: Adults 18 years of age and older: Lamotrix is indicated for the prevention of depressive episodes in patients with bipolar disorder. Safety and efficacy of lamotrigine in the acute treatment of mood episodes has not been established. The physician who elects to use lamotrigine for periods extending beyond 18 months should periodically re-evaluate the long-term usefulness of the drug for the individual patient.